| pubmed-article:18534980 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18534980 | lifeskim:mentions | umls-concept:C0010760 | lld:lifeskim |
| pubmed-article:18534980 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
| pubmed-article:18534980 | lifeskim:mentions | umls-concept:C1519726 | lld:lifeskim |
| pubmed-article:18534980 | lifeskim:mentions | umls-concept:C0030013 | lld:lifeskim |
| pubmed-article:18534980 | lifeskim:mentions | umls-concept:C1711351 | lld:lifeskim |
| pubmed-article:18534980 | pubmed:issue | 30 | lld:pubmed |
| pubmed-article:18534980 | pubmed:dateCreated | 2008-7-21 | lld:pubmed |
| pubmed-article:18534980 | pubmed:abstractText | Mitochondrial oxidative phosphorylation provides most cellular energy. As part of this process, cytochrome c oxidase (CcO) pumps protons across the inner mitochondrial membrane, contributing to the generation of the mitochondrial membrane potential, which is used by ATP synthase to produce ATP. During acute inflammation, as in sepsis, aerobic metabolism appears to malfunction and switches to glycolytic energy production. The pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) has been shown to play a central role in inflammation. We hypothesized that TNFalpha-triggered cell signaling targets CcO, which is a central enzyme of the aerobic energy metabolism and can be regulated through phosphorylation. Using total bovine and murine hepatocyte homogenates TNFalpha treatment led to an approximately 60% reduction in CcO activity. In contrast, there was no direct effect of TNFalpha on CcO activity using isolated mitochondria and purified CcO, indicating that a TNFalpha-triggered intracellular signaling cascade mediates CcO inhibition. CcO isolated after TNFalpha treatment showed tyrosine phosphorylation on CcO catalytic subunit I and was approximately 50 and 70% inhibited at high cytochrome c concentrations in the presence of allosteric activator ADP and inhibitor ATP, respectively. CcO phosphorylation occurs on tyrosine 304 as demonstrated with a phosphoepitope-specific antibody. Furthermore, the mitochondrial membrane potential was decreased in H2.35 cells in response to TNFalpha. Concomitantly, cellular ATP was more than 35 and 64% reduced in murine hepatocytes and H2.35 cells. We postulate that an important contributor in TNFalpha-mediated pathologies, such as sepsis, is energy paucity, which parallels the poor tissue oxygen extraction and utilization found in such patients. | lld:pubmed |
| pubmed-article:18534980 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18534980 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18534980 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18534980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18534980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18534980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18534980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18534980 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18534980 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18534980 | pubmed:issn | 0021-9258 | lld:pubmed |
| pubmed-article:18534980 | pubmed:author | pubmed-author:LottspeichFri... | lld:pubmed |
| pubmed-article:18534980 | pubmed:author | pubmed-author:HüttemannMaik... | lld:pubmed |
| pubmed-article:18534980 | pubmed:author | pubmed-author:SamavatiLobel... | lld:pubmed |
| pubmed-article:18534980 | pubmed:author | pubmed-author:LeeIcksooI | lld:pubmed |
| pubmed-article:18534980 | pubmed:author | pubmed-author:MathesIsabell... | lld:pubmed |
| pubmed-article:18534980 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18534980 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:18534980 | pubmed:volume | 283 | lld:pubmed |
| pubmed-article:18534980 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18534980 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18534980 | pubmed:pagination | 21134-44 | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:meshHeading | pubmed-meshheading:18534980... | lld:pubmed |
| pubmed-article:18534980 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18534980 | pubmed:articleTitle | Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. | lld:pubmed |
| pubmed-article:18534980 | pubmed:affiliation | Department of Medicine, Division of Pulmonary/Critical Care and Sleep Medicine, Wayne State University School of Medicine, 3990 John R., Detroit, MI 48201, USA. lsamavat@med.wayne.edu | lld:pubmed |
| pubmed-article:18534980 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18534980 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:280943 | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| entrez-gene:3283879 | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| entrez-gene:17708 | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| entrez-gene:21926 | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18534980 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18534980 | lld:pubmed |
